Ignite Creation Date:
2024-05-06 @ 3:55 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02409186
Status:
UNKNOWN
Last Update Posted:
2016-04-21
First Post:
2014-12-03
Brief Title:
A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma
Sponsor:
Organization:
Shandong Cancer Hospital and Institute